A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Mitapivat (AG-348) in Healthy Adult Participants
Clinical trial NCT04472832 · COMPLETED
Trial details
- NCT number
- NCT04472832
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-17
- Primary completion
- 2020-11-23
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.